Showing results (101-110 of 362) with videos related to
Sort By:
Pageof 37
Bone Marrow Transplantation|June 1, 1994
Late development of graft-versus-host disease in an autologous BMT recipientA L Appleton, L Sviland, J Wilkes, et al.The British Journal of Cancer. Supplement|August 1, 1992
The influence of age on nephrotoxicity following chemotherapy in childrenR Skinner, A D Pearson, L Price, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
21-day schedule oral etoposide in children--a feasibility studyA Davidson, I Lewis, A D Pearson, et al.Biochemical Pharmacology|February 25, 2000
Camptothecin-stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining)K Padget, R Carr, A D Pearson, et al.Cancer Research|February 24, 2001
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell lineD A Tweddle, A J Malcolm, N Bown, et al.Genes, Chromosomes & Cancer|July 1, 1997
Promiscuous translocations of chromosome arm 17q in human neuroblastomasM Lastowska, P Roberts, A D Pearson, et al.Archives of Disease in Childhood|July 1, 1990
Nephrotoxicity after ifosfamideR Skinner, A D Pearson, L Price, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology GroupE J Estlin, S Cotterill, C B Pratt, et al.British Journal of Cancer|October 1, 1993
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosisE Jaros, J Lunec, R H Perry, et al.The American Journal of Pathology|June 8, 2001
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cellsD A Tweddle, A J Malcolm, M Cole, et al.Pageof 37